www.hivandhepatitis.com

Back HCV Disease Progression

AASLD 2013: Aspirin and Cenicriviroc May Help Reduce Liver Fibrosis

Details
Category: Fibrosis & Cirrhosis
Published on Tuesday, 26 November 2013 00:00
Written by Liz Highleyman
  • Print

Hepatitis C patients who took low-dose aspirin after liver transplantation experienced slower fibrosis progression, researchers reported at the AASLD Liver Meeting this month in Washington, DC. Two other studies showed that cenicriviroc -- a drug being developed for HIV treatment that blocks both CCR5 and CCR2 cell surface receptors -- had anti-inflammatory and anti-fibrotic activity in mice and rats.

alt

Read more:

More Articles...

  1. AASLD 2013: Hepatitis C Treatment Reduces Liver Cancer and Death, But Most Remain Untreated
  2. Coverage of the 2013 AASLD Liver Meeting
  3. Coffee and Chocolate May Reduce Liver Inflammation in HIV/HCV Coinfected People
  4. Sex, Genotype, and IL28B Pattern Predict Spontaneous HCV Clearance
  5. IAS 2013: FibroScan Predicts Liver Decompensation and Death Among HIV/HCV Coinfected People

Subcategories

Copyright © 2025 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design